Europe Home Healthcare Market Analysis and Opportunities by 2028
Historic Data: 2019-2020 | Base Year: 2021 | Forecast Period: 2022-2028Europe Home Healthcare Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Therapeutic, Diagnostic, and Mobility Assist), Indication (Cancer, Respiratory Diseases, Mobility Disorders, Cardiovascular Disorders, Pregnancy, Wound Care, Diabetes, and Other Indications), and Service (Skilled Nursing, Rehabilitation Therapy, Hospice and Palliative Care, Unskilled Care, Respiratory Therapy, Infusion Therapy, and Pregnancy Care)
- Report Date : Jul 2021
- Report Code : TIPRE00023453
- Category : Life Sciences
- Status : Published
- Available Report Formats :
- No. of Pages : 151
The Europe home healthcare market is expected to reach US$ 176,618.77 million by 2028 from US$ 99,236.36 million in 2021; it is estimated to grow at a CAGR of 8.6% from 2021 to 2028.
The growth of the market in Europe is attributed to the surging preference for home healthcare settings among patients and care providers, and rising focus on telehealth. However, limited insurance coverage and patient safety concerns are obstructing the market growth to a certain extent.Home healthcare encompasses a wide range of healthcare services provided for managing illnesses at home. Growing support from the government to encourage establishment of home care settings by encouraging the launch of product required for home care settings are the prominent factors supporting the growth of the home healthcare market in North America. Countries such as the UK and Germany have been supporting the hospital-at-home programs that provide flexibility to hospitals to provide patients with hospital-level care in their homes. Moreover, the home care setting industry has experienced a rise due to various product launches, collaborations, and innovations by the market players. Therefore, such strategies by the market players are likely to accelerate the market growth in the coming years. Health systems in European countries are adopting telehealth as a tool to extend care at homes to achieve improved outcomes at reduced costs. This is likely to encourage the introduction of more portable and affordable home healthcare devices. Apart from this, increasing partnerships among service providers is further propelling the growth of the market.
As COVID-19 continues to burden health care institutions, the preference for home-based care is growing at a rapid pace. The COVID-19 pandemic has a mixed impact on the Europe home healthcare market. It is boosting the adoption of home healthcare monitoring products such as blood glucose monitors, blood pressure monitors, pulse oximeters, and temperature monitors. However, many other companies and service providers have experienced decline in sales due to the discontinuation of manufacturing operations and disruption of supply chains. However, this downturn in is expected to continue for a short term, as the business are gradually picking pace post lockdown. Also, increasing collaborative efforts between service providers is offering lucrative opportunities for the market growth. The pandemic has encouraged trends favoring home care as an alternative to frequent hospital visits.
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
EUROPE HOME HEALTHCARE MARKET SEGMENTATION
By Product Type
- Therapeutic
- Diagnostic
- Mobility assist
By Indication
- Cancer
- Respiratory Diseases
- Cardiovascular Disorders
- Mobility Disorders
- Wound Care
- Diabetes
- Pregnancy
- Other Indications
By Service
- Skilled Nursing
- Rehabilitation Therapy
- Hospice and Palliative Care
- Unskilled Care
- Respiratory Therapy
- Infusion Therapy
- Pregnancy Care
By Country
- UK
- Germany
- France
- Italy
- Spain
- Rest of Europe
Company Profiles
- Fresenius SE & Co. KGaA
- General Electric Company
- LINDE
- F. HOFFMANN-LA ROCHE LTD
- A&D Company, Limited
- BAYADA Home Health Care
- Invacare Corporation
Europe Home Healthcare Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 99,236.36 Million |
| Market Size by 2028 | US$ 176,618.77 Million |
| Global CAGR (2021 - 2028) | 8.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Product Type
|
| Regions and Countries Covered | Europe
|
| Market leaders and key company profiles |
Frequently Asked Questions
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Global, Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Testimonials
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
Jean-Herve Jenn Chairman, Future AnalyticaReason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Yes! We provide a free sample of the report, which includes Report Scope (Table of Contents), report structure, and selected insights to help you assess the value of the full report. Please click on the "Download Sample" button or contact us to receive your copy.
Absolutely — analyst assistance is part of the package. You can connect with our analyst post-purchase to clarify report insights, methodology or discuss how the findings apply to your business needs.
Once your order is successfully placed, you will receive a confirmation email along with your invoice.
• For published reports: You’ll receive access to the report within 4–6 working hours via a secured email sent to your email.
• For upcoming reports: Your order will be recorded as a pre-booking. Our team will share the estimated release date and keep you informed of any updates. As soon as the report is published, it will be delivered to your registered email.
We offer customization options to align the report with your specific objectives. Whether you need deeper insights into a particular region, industry segment, competitor analysis, or data cut, our research team can tailor the report accordingly. Please share your requirements with us, and we’ll be happy to provide a customized proposal or scope.
The report is available in either PDF format or as an Excel dataset, depending on the license you choose.
The PDF version provides the full analysis and visuals in a ready-to-read format. The Excel dataset includes all underlying data tables for easy manipulation and further analysis.
Please review the license options at checkout or contact us to confirm which formats are included with your purchase.
Our payment process is fully secure and PCI-DSS compliant.
We use trusted and encrypted payment gateways to ensure that all transactions are protected with industry-standard SSL encryption. Your payment details are never stored on our servers and are handled securely by certified third-party processors.
You can make your purchase with confidence, knowing your personal and financial information is safe with us.
Yes, we do offer special pricing for bulk purchases.
If you're interested in purchasing multiple reports, we’re happy to provide a customized bundle offer or volume-based discount tailored to your needs. Please contact our sales team with the list of reports you’re considering, and we’ll share a personalized quote.
Yes, absolutely.
Our team is available to help you make an informed decision. Whether you have questions about the report’s scope, methodology, customization options, or which license suits you best, we’re here to assist. Please reach out to us at sales@theinsightpartners.com, and one of our representatives will get in touch promptly.
Yes, a billing invoice will be automatically generated and sent to your registered email upon successful completion of your purchase.
If you need the invoice in a specific format or require additional details (such as company name, GST, or VAT information), feel free to contact us, and we’ll be happy to assist.
Yes, certainly.
If you encounter any difficulties accessing or receiving your report, our support team is ready to assist you. Simply reach out to us via email or live chat with your order information, and we’ll ensure the issue is resolved quickly so you can access your report without interruption.
- Fresenius SE & Co. KGaA
- General Electric Company
- LINDE
- F. HOFFMANN-LA ROCHE LTD
- A&D Company, Limited
- BAYADA Home Health Care
- Invacare Corporation
Get Free Sample For